Identification of potential biomarkers for idiopathic pulmonary fibrosis and validation of TDO2 as a potential therapeutic target

Figure 5 mRNA expression levels of TDO2, COL3A1, KCNN4, SULF1, HSD17B6, KCNMA1, KCNMB4, ALDH1A3, and SDR16C5 in the lung tissue vs PBS (n = 5 for PBS group, n = 5 for Bleo group). The statistical test used was the t test. Data are expressed as the mean with SD. ^aP < 0.01, ^bP < 0.05.